US 7790158
Methods for epitope-specific and cytokine/anticytokine combination immunotherapies
granted A61KA61K2039/505A61K38/1793
Quick answer
US patent 7790158 (Methods for epitope-specific and cytokine/anticytokine combination immunotherapies) held by The Regents of the University of California expires Mon Sep 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Sep 07 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61K, A61K2039/505, A61K38/1793, A61K38/19, A61K39/0008